Tag: Bleeding
PhaseBio poised to make rapid strides in the Anti-Coagulant Reversal Market
PhaseBio’s (NASDAQ: PHAS), PB2452 is the new drug on the block, which has received a breakthrough therapy status from the FDA in April 2019....
TG Therapeutics – Spearheading Innovations in Lymphoma Treatment
TG Therapeutics (NASDAQ: TGTX), a clinical stage company that is leading the innovation bandwagon in the field of novel therapies for B-cell malignancies and autoimmune...
We are looking for talented interns to learn and help investors find valuable companies.